Search Results - "Kung, Hank"
-
1
PET/SPECT imaging agents for neurodegenerative diseases
Published in Chemical Society reviews (07-10-2014)“…Single photon emission computed tomography (SPECT) or positron emission computed tomography (PET) imaging agents for neurodegenerative diseases have a…”
Get more information
Journal Article -
2
Head-to-head comparison of [68Ga]Ga-P16-093 and 2-[18F]FDG PET/CT in patients with clear cell renal cell carcinoma: a pilot study
Published in European journal of nuclear medicine and molecular imaging (01-04-2023)“…Purpose This pilot study was prospectively designed to evaluate and compare the diagnostic value of PET/CT using a PSMA-specific tracer [ 68 Ga]Ga-P16-093 and…”
Get full text
Journal Article -
3
68Ga/177Lu-Labeled Bivalent Agents for Targeting Hypoxia and PSMA-Binding in Prostate Cancer
Published in Journal of medicinal chemistry (08-08-2024)“…Prostate-specific membrane antigen (PSMA) is an excellent target for cancer detection and therapy. Hypoxia is prevalent in solid tumors, and various…”
Get full text
Journal Article -
4
68 Ga/ 177 Lu-Labeled Bivalent Agents for Targeting Hypoxia and PSMA-Binding in Prostate Cancer
Published in Journal of medicinal chemistry (08-08-2024)“…Prostate-specific membrane antigen (PSMA) is an excellent target for cancer detection and therapy. Hypoxia is prevalent in solid tumors, and various…”
Get full text
Journal Article -
5
The β-Amyloid Hypothesis in Alzheimer's Disease: Seeing Is Believing
Published in ACS medicinal chemistry letters (12-04-2012)Get full text
Journal Article -
6
Metabolic Imaging of Glutamine in Cancer
Published in Journal of Nuclear Medicine (01-04-2017)“…Glucose and glutamine are the most abundant nutrients for producing energy and building blocks in normal and tumor cells. Increased glycolysis in tumors, the…”
Get full text
Journal Article -
7
Glutamine-based PET imaging facilitates enhanced metabolic evaluation of gliomas in vivo
Published in Science translational medicine (11-02-2015)“…Glucose and glutamine are the two principal nutrients that cancer cells use to proliferate and survive. Many cancers show altered glucose metabolism, which…”
Get more information
Journal Article -
8
New PSMA-Targeting Ligands: Transformation from Diagnosis (Ga-68) to Radionuclide Therapy (Lu-177)
Published in Journal of medicinal chemistry (13-10-2022)“…Prostate-specific membrane antigen (PSMA) is a promising target for the diagnosis and radionuclide therapy of prostate cancer. This study reports conversion of…”
Get full text
Journal Article -
9
Theranostic Agent Targeting Bone Metastasis: A Novel [68Ga]Ga/[177Lu]Lu-DOTA-HBED-bisphosphonate
Published in Journal of medicinal chemistry (28-03-2024)“…Bone metastasis in cancer patients is a major disease advancement for various types of cancer. Previously, [68Ga]Ga-HBED-CC-bisphosphonate ([68Ga]Ga-P15-041)…”
Get full text
Journal Article -
10
Lu-177-Labeled Hetero-Bivalent Agents Targeting PSMA and Bone Metastases for Radionuclide Therapy
Published in Journal of medicinal chemistry (14-09-2023)“…Prostate-specific membrane antigen (PSMA) is an excellent target for imaging and radionuclide therapy of prostate cancer. Recently, [177Lu]Lu-PSMA-617…”
Get full text
Journal Article -
11
Preclinical evaluation of [18F]D3FSP, deuterated AV-45, for imaging of β-amyloid in the brain
Published in Nuclear medicine and biology (01-01-2021)“…Since the approval of three 18F labeled β-amyloid-targeting PET imaging agents, Amyvid (florbetapir f18, AV-45), Neuraceq (florbetaben f18, AV-1) and Vizamyl…”
Get full text
Journal Article -
12
A prospective head-to-head comparison of [68Ga]Ga-P16-093 and [68Ga]Ga-PSMA-11 PET/CT in patients with primary prostate cancer
Published in European journal of nuclear medicine and molecular imaging (01-08-2023)“…Purpose We aimed to compare the diagnostic performance and biodistribution of two similar PET agents, [ 68 Ga]Ga-P16-093 and [ 68 Ga]Ga-PSMA-11, in the same…”
Get full text
Journal Article -
13
Synthesis and Evaluation of 68Ga- and 177Lu-Labeled (R)- vs (S)‑DOTAGA Prostate-Specific Membrane Antigen-Targeting Derivatives
Published in Molecular pharmaceutics (07-12-2020)“…Prostate-specific membrane antigen (PSMA) is overexpressed in prostate cancer cells and therefore is an attractive target for prostate cancer diagnosis and…”
Get full text
Journal Article -
14
Serotonin transporter imaging agent as a probe for β-cells of pancreas
Published in Nuclear medicine and biology (01-03-2024)“…Diabetes mellitus (DM) is one of the major diseases in the world. Nuclear medicine imaging may be able to detect functional status of pancreatic β cells in…”
Get full text
Journal Article -
15
Head-to-head comparison of [68 Ga]Ga-P16-093 and [68 Ga]Ga-PSMA-617 in dynamic PET/CT evaluation of the same group of recurrent prostate cancer patients
Published in European journal of nuclear medicine and molecular imaging (01-02-2022)“…Purpose This study was prospectively designed to evaluate the early dynamic organ distribution and tumor detection capability of [ 68 Ga]Ga-P16-093, which was…”
Get full text
Journal Article -
16
Synthesis and evaluation of a novel urea-based 68Ga-complex for imaging PSMA binding in tumor
Published in Nuclear medicine and biology (01-04-2018)“…Prostate specific membrane antigen (PSMA) is a well-established target for diagnostic and therapeutic applications for prostate cancer. It is know that…”
Get full text
Journal Article -
17
Novel [68Ga/177Lu]Ga/Lu-AZ-093 as PSMA-Targeting Agent for Diagnosis and Radiotherapy
Published in Molecular pharmaceutics (01-07-2024)“…Prostate-specific membrane antigen (PSMA) overexpressed in prostate cancer cells can serve as a target for imaging and radioligand therapy (RLT). Previously,…”
Get full text
Journal Article -
18
5-HT1A autoreceptor levels determine vulnerability to stress and response to antidepressants
Published in Neuron (Cambridge, Mass.) (14-01-2010)“…Most depressed patients don't respond to their first drug treatment, and the reasons for this treatment resistance remain enigmatic. Human studies implicate a…”
Get full text
Journal Article -
19
Radiolabeling Optimization and Preclinical Evaluation of the New PSMA Imaging Agent [18F]AlF-P16-093
Published in Bioconjugate chemistry (19-05-2021)“…Prostate-specific membrane antigen (PSMA)-targeted radioligands have played an increasing role in the diagnosis of prostate cancer. [68Ga]Ga-P16-093 is a…”
Get full text
Journal Article -
20
A New [68Ga]Ga-HBED-CC-Bisphosphonate as a Bone Imaging Agent
Published in Molecular pharmaceutics (04-05-2020)“…Positron emission tomography (PET) imaging using 68Ga-labeled bisphosphonates to target bone metastasis could be a valuable tool in cancer diagnosis and…”
Get full text
Journal Article